Pregnancy and diabetes management: Advances and controversies

Clinical Chemistry

Volumn 57, Issue 2, 2011, Pages 221-230

  Castorino, Kristin ^a   Jovanovič, Lois ^a  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; APIDAR; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LIRAGLUTIDE; METFORMIN; MIGLITOL; NATEGLINIDE; NOVALOG; PIG INSULIN; PIOGLITAZONE; PRAMLINTIDE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; UNCLASSIFIED DRUG;

DIET; DRUG EFFICACY; DRUG SAFETY; GESTATION PERIOD; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; INTRAPARTUM CARE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REVIEW; SCREENING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LACTATION; PERIPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 79551489602     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.155382     Document Type: Review

References (77)

1. Evers I, de Valk H, Visser G. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915.
2. Mahmud M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Womens Health 2010;31:10.
3. Pearson D, Kernaghan D, Lee R, Penney GC. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type 1 diabetes mellitus. BJOG 2007;114:104-7.
4. Ray J, O'Brien T, Chan W. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a metaanalysis. QJM 2001;94:435-44.
5. Guerin A, Nisenbaum R, Ray J. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920-5.
6. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 2002;325:1275.
7. California Diabetes in Pregnancy Project Website. http://www.cdph.ca.gov/ programs/cdapp/Pages/default.aspx, including CDPP Fact Sheet http://www.cdph.ca.gov/data/statistics/Documents/MOCDAPP- GDM-FactSheet.pdf (Accessed July 2010).
8. Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med 2010;48:609-14.
9. Jovanovič L, Savas H, Mehta M, Trujillo A, Pettitt D. Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy [Abstract]. Diabetes 2010;59(Suppl 1):A507-8.
10. Mills J, Baker L, Goldman A. Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 1979;28:292-3.
11. Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, Mathiesen ER. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200-1.
12. Kerssen, A, Evers, I, de Valk, H, Visser, G. Poor glucose control in women with type 1 diabetes mellitus and "safe" hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med 2003;13:309-13.
13. Center for Disease Control. National diabetes fact sheet. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf (Accessed July 2010).
14. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
15. Metzger B, Lowe, L, Dyer A, Trimble E, Chaovarindr U, Coustan D, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
16. American Academy of Clinical Endocrinology: AACE Diabetes Mellitus Guidelines. Endoc Pract 2007;13(Suppl 1). http://www.aace.com/pub/pdf/ guidelines/DMGuidelines2007.pdf.
17. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458-64.
18. Mauricio D, Balsells M, Morales J, Corcoy R, Puig-Domingo M, de Leiva A. Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996;12:275-85.
19. Ferber KM, Keller E, Alber ED, Ziegler AG. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 1999;84:2342.
20. Jensen D, Damm P, Sørensen B, Mølsted-Pedersen L, Westergaard J, Klebe J, Beck-Nielsen H. Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001;185:413-9.
21. Ferrara A, Weiss N, Hedderson M, Quesenberry C Jr, Selby J, Ergas I, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298-306.
22. Jensen D, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008;87:59-62.
23. Sermer M, Naylor C, Gare D, Kenshole A, Ritchie J, Farine D, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146-56.
24. Sermer M, Naylor C, Farine D, Kenshole A, Ritchie J, Gare D, et al. The Toronto Tri-Hospital Gestational Diabetes Project: a preliminary review. Diabetes Care 1998;(Suppl 2):B33-42.
25. Sacks, D, Greenspoon, J, Abu-Fadil, S, Henry H, Wolde-Tsadik G, Yao J. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 1995;172:607-14.
26. Pettitt D, Knowler W. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 1998;21(Suppl 2):B138-41.
27. Hillier T, Pedula K, Schmidt M, Mullen J, Charles M, Pettitt D. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007;30:2287-92.
28. Boney C, Verma A, Tucker R, Vohr B. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:290-6.
29. Pettitt D, Jovanovič L. The vicious cycle of diabetes and pregnancy. Curr Diab Rep 2007;7:295-7.
30. Metzger B. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1991;30(Suppl 2):197-201.
31. O'Sullivan J, Mahan C. Prospective study of 352 young patients with chemical diabetes. N Engl J Med 1968;278:1038-41.
32. Reitnakaran R, Ying Q, Sermer M, Connelly P, Hanley A, Zinman B. B-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care 2010;33:1798-804.
33. Landon MB, Mintz MC, Gabbe SG. Sonographic evaluation of fetal abdominal growth: predictor of the large-for-gestational-age infant in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1989;160:115-21.
34. Dodd J, Crowther C, Antoniou G, Baghurst P, Robinson J. Screening for gestational diabetes: the effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Aust N Z J Obstet Gynaecol 2007;47:307-12.
35. Leipold H, Worda C, Schwindt J, Kautzky-Willer A, Bancher-Todesca D, Husslein PW. Severe diabetic fetopathy despite strict metabolic control. Wien Klin Wochenschr 2005;117:561-4.
36. Landon M, Spong C, Thom E, Carpenter M, Ramin S, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009 Oct 1;361:1339-48.
37. Hone J, Jovanovič L. Approach to the patient with diabetes during pregnancy. J Clin Endocrinol Metab 2010;95:3578-85.
38. Bühling KJ, Winkel T, Wolf C, Kurzidim B, Mahmoudi M, Wohlfarth K, et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). J Perinat Med 2005;33:125-31.
39. Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovič L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003;101:633-8.
40. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ. 2008;337:a1680.
41. Byrne EZ, Zisser HC, Jovanovič L. Continuous glucose monitoring: is it helpful in pregnancy? Curr Diabetes Rev. 2008;4:223-6.
42. Pettitt D, Ospina P, Kolaczynski J, Jovanovič L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 2003;26:183-6.
43. Wyatt J, Frias J, Hoyme H, Jovanovič L, Kaaja R, Brown F, et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 2005;22:803-7.
44. Heller S, Damm P, Mersebach H, Skjøth T, Kaaja R, Hod M, et al. Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes Care 2010;33:473-7.
45. Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007 Apr;30:771-6.
46. McCance DR, Damm P, Mathiesen ER, Hod M, Kaaja R, Dunne F, et al. Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus. Diabetologia 2008;51:2141-3.
47. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 2008;25:165-9.
48. Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A et al. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study. Clin Ther 2008;30:1476-84.
49. Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, et al. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol 2007;66:322-8.
50. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care 2005;28:2594-5.
51. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, Trüb T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000 Jun;49:999-1005.
52. Jovanovič L, Druzin M, Peterson CM. Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects. Am J Med 1981;71:921-7.
53. Wollitzer AD, Zisser H, Jovanovič L. Insulin pumps and their use in pregnancy. Diabetes Technol Ther 2010;12(Suppl 1):S33-6.
54. Moore L, Clokey D, Rappaport V, Curet L. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol 2010;115:55-9.
55. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004;104:88-93.
56. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales, O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
57. Langer O, Yogev Y, Xenakis, EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 2005;192:134-9.
58. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol 2004;190:1438-9.
59. Ekpebegh CO, Coetzee EJ, van der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med 2007;24:253-8.
60. Hellmuth E, Damm P, Mølsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000;17:507-11.
61. Ota H, Goto T, Yoshioka T, Ohyama N. Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome. Fertil Steril 2008;90:709-13.
62. Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol 2010;202:383.e1-7.
63. Institute of Medicine. Dietary reference intakes. Part 2. Washington, DC: National Academies Press; 2002.
64. Jovanovič L, Peterson CM. Nutritional management of the obese gestational diabetic woman. J Am Coll Nutr 1992;11:246-50.
65. Peterson C. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 1991;40(Suppl 2):172-4.
66. United States Department of Agriculture. foodpyramid.com (Accessed July 2010).
67. Catalano, P. Management of obesity in pregnancy. Obstet Gynecol 2007;109:419-33.
68. Rasmussen K, Yaktine A, eds. Committee to Reexamine IOM Pregnancy Weight Guidelines; Institute of Medicine; National Research Council. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009.
69. Nygaard H, Tomten SE, Høstmark AT. Slow post-meal walking reduces postprandial glycemia in middle-aged women. Appl Physiol Nutr Metab 2009;34:1087-92.
70. Iafusco D, Stoppoloni F, Salvia G, Vernetti G, Passaro P, Petrovski G, Prisco F. Use of real time continuous glucose monitoring and intravenous insulin in type 1 diabetic mothers to prevent respiratory distress and hypoglycaemia in infants. BMC Pregnancy Childbirth 2008;8:23.
71. Davies HA, Clark JD, Dalton KJ, Edwards OM. Insulin requirements of diabetic women who breast feed. BMJ 1989;298:1357-8.
72. Lawrence RA, Lawrence RM. Breastfeeding: a guide for the medical profession. 6th ed. Philadelphia: Elsevier Mosby; 2005.
73. Ziegler AG, Schmid S, Huber D, Hummel M. Early infant feeding and the risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1721-8.
74. Gerstein HC. Cow's milk exposure and type I diabetes mellitus: a critical overview of the clinical literature. Diabetes Care 1994;17:13-9.
75. Jovanovic-Peterson L, Bevier W, Peterson CM. The Santa Barbara County Health Care Services program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention? Am J Perinatol 1997;14:221-8.
76. Physician's Desk Reference Network. www.pdr.net (Accessed August 2010).
77. National Institutes of Health. U.S. National Library of Medicine. http://www.ncbi.nlm.nih.gov/pubmed (Accessed August 2010).